Abd-rabou, A., H. Ahmed, and E. Eskander. “CLEMASTINE, THE H1 HISTAMINE RECEPTOR ANTAGONIST, ALTERS THE HUMAN SEX AND THYROID HORMONAL PROFILES”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 10, no. 8, Aug. 2017, pp. 327-30, doi:10.22159/ajpcr.2017.v10i8.19456.